MCI - NYSE

Barings Corporate Investors

MCI·NYSE

$17.41

-2.0%

Financial ServicesAsset Management

Babson Capital Corporate Investors trust is a closed ended fixed income mutual fund launched and managed by Barings LLC. It invests in fixed income markets of the United States. The fund seeks to invest in securities of companies operating across diversified sectors. It primarily invests in a portfolio of privately placed, below-investment grade, long term corporate debt obligations. The fund also invests in marketable investment grade debt securities, other marketable debt securities, and marketable common stocks. It was formerly known as Babson Capital Corporate Investors. Babson Capital Corporate Investors trust was formed in 1971 and is domiciled in the United States.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$357.88M

EPS1.3700

P/E Ratio12.71

Earnings Date05/15/2025

431.22M

Assets

3Y+12.0%

5Y+25.0%

10Y+34.0%

89.92M

Total Liabilities

43%

3Y+65.0%

5Y+129.0%

10Y+123.0%

341.30M

Total Equity

-1%

3Y+3.0%

5Y+12.0%

10Y+21.0%

Barings Corporate Investors Funding & Solvency Profile

MCI · NYSE

Current Assets

Cash & Cash Equivalents32.12M

Net Receivables0.00

Inventory0.00

Other Current Assets0.00

Total Current Assets32 M

Non-Current Assets

Property, Plant & Equipment0.00

Goodwill & Intangible Assets0.00

Long-Term Investments0.00

Other Non-Current Assets399.09M

Total Non-Current Assets399 M

Total Assets

431.22M

Financial Health Analysis

Current Ratio

2.19x

Excellent liquidity position. The company can easily cover its short-term obligations with substantial cushion.

Debt-to-Equity Ratio

0.26x

Conservative capital structure. The company relies primarily on equity financing, indicating low financial risk.

Working Capital

17 M

Strong working capital position provides significant operational flexibility and financial cushion.

Asset Composition

7% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Financial Health Insight

Strong financial foundation: Excellent liquidity combined with conservative leverage suggests the company is well-positioned to weather economic uncertainties and fund growth opportunities.

Barings Corporate Investors Balance Sheet

MCI • NYSE

Barings Corporate Investors Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	32.1M	17.2M	14.9M	13.2M	21.2M	29.9M	24.1M	27.1M	7.2M	14.3M	8.9M	12.5M	23.8M	4.8M
Cash & Short-Term Investments	32.1M	17.2M	14.9M	13.2M	21.2M	29.9M	24.1M	27.1M	7.2M	14.3M	8.9M	12.5M	23.8M	4.8M
Net Receivables	0.0	10.1M	5.9M	5.5M	3.9M	2.5M	2.1M	2.4M	2.9M	3.7M	3.5M	3M	2.4M	2.3M
Accounts Receivables	0.0	10.1M	5.9M	5.5M	3.9M	2.5M	2.1M	2.4M	2.9M	3.7M	3.5M	3M	2.4M	0.0
Other Current Assets	0.0	0.0	595.3K	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Current Assets	32.1M	27.3M	21.4M	18.7M	25.1M	32.3M	26.2M	29.6M	10.2M	18M	12.4M	15.5M	26.2M	7.1M
NON-CURRENT ASSETS
Long-Term Investments	0.0	0.0	372.2M	0.0	0.0	309.3M	320.6M	300.7M	336.5M	46.2M	47.8M	68.5M	46.6M	38.5M
Other Non-Current Assets	399.1M	379M	0.0	367.4M	362M	2.4M	0.0	-300.7M	-336.5M	257.7M	255.5M	238.9M	235.5M	-38.5M
Total Non-Current Assets	399.1M	379M	372.2M	367.4M	362M	311.7M	320.6M	300.7M	336.5M	303.9M	303.3M	307.4M	282.2M	38.5M
Other Assets	0.0	0.0	330.4K	0.0	0.0	0.0	2.6K	2.6K	25.8K	0.0	0.0	0.0	0.0	253.8M
Total Assets	431.2M	406.2M	393.9M	386.1M	387.1M	344M	346.8M	330.3M	346.7M	321.9M	315.7M	322.9M	308.4M	299.4M
LIABILITIES
CURRENT LIABILITIES
Total Payables	14.7M	13.7M	7.9M	5.9M	6.8M	2.9M	186.2K	8.9M	11.5M	0.0	0.0	0.0	520.1K	0.0
Accounts Payable	12.9M	13.7M	7.9M	5.9M	6.8M	2.9M	186.2K	6.2M	6.1M	0.0	0.0	0.0	520.1K	0.0
Other Payables	1.8M	0.0	0.0	0.0	0.0	0.0	0.0	-6.2M	-6.1M	0.0	0.0	0.0	0.0	0.0
Accrued Expenses	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3M	1.4M	1.4M	1.3M	0.0
Tax Payables	710K	950K	900K	650K	2.6M	429.8K	1.1M	1.9M	4.4M	0.0	0.0	0.0	0.0	0.0
Other Current Liabilities	0.0	0.0	0.0	0.0	0.0	5M	6.2M	-8.9M	-11.5M	8.1M	7.3M	10.2M	6.5M	11.1M
Total Current Liabilities	14.7M	13.7M	7.9M	5.9M	6.8M	7.9M	6.4M	6.2M	6.1M	9.4M	8.7M	11.6M	8.4M	11.1M
NON-CURRENT LIABILITIES
Long Term Debt	74.7M	45.9M	42.3M	46M	38M	30M	0.0	0.0	0.0	30M	30M	30M	30M	30M
Other Non-Current Liabilities	495.6K	3.1M	0.0	2.6M	4.2M	0.0	0.0	0.0	0.0	1M	1.1M	1.2M	1.3M	-30M
Total Non-Current Liabilities	75.2M	48.9M	42.3M	48.6M	42.2M	30M	30M	30M	30M	31M	31.1M	31.2M	31.3M	30M
Other Liabilities	0.0	0.0	3.9M	0.0	0.0	1.4M	2.1M	2.9M	7M	0.0	0.0	0.0	0.0	902K
Total Liabilities	89.9M	62.7M	54.1M	54.4M	49.1M	39.3M	38.5M	39M	43.2M	40.4M	39.8M	42.7M	39.7M	42M
SHAREHOLDERS' EQUITY
Common Stock	20.5M	20.4M	20.3M	20.3M	20.3M	20.3M	20.2M	20.1M	19.9M	19.8M	19.7M	19.5M	19.4M	19.2M
Additional Paid-In Capital	280.1M	278.5M	277M	277.9M	278.7M	272.5M	272.1M	270.7M	109.7M	111M	111.4M	114.6M	113.6M	0.0
Retained Earnings	40.7M	44.7M	42.6M	33.5M	39.1M	11.9M	15.9M	427.5K	158.5M	150.7M	144.8M	146M	135.7M	127.5M
Accumulated Other Comprehensive Income/Loss	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	90.0	0.0	0.0	0.0	0.0
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	110.6M
Total Stockholders' Equity	341.3M	343.6M	339.8M	331.6M	338M	304.7M	308.2M	291.2M	303.5M	281.6M	275.9M	280.1M	268.7M	257.4M
Total Equity	341.3M	343.6M	339.8M	331.6M	338M	304.7M	308.2M	291.2M	303.5M	281.6M	275.9M	280.1M	268.7M	257.4M
SUMMARY
Total Liabilities & Equity	431.2M	406.2M	393.9M	386.1M	387.1M	344M	346.8M	330.3M	346.7M	321.9M	315.7M	322.9M	308.4M	0.0
Total Investments	0.0	0.0	372.2M	0.0	0.0	309.3M	320.6M	300.7M	336.5M	46.2M	47.8M	68.5M	46.6M	38.5M
Total Debt	74.7M	45.9M	42.3M	46M	38M	30M	30M	30M	30M	30M	30M	30M	30M	0.0
Net Debt	42.6M	28.6M	27.4M	32.8M	16.8M	148.4K	5.9M	2.9M	22.8M	15.7M	21.1M	17.5M	6.2M	-4.8M
Shares Outstanding	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728	20,467,728

SEC Filings

MCI - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
DEF 14A DEF 14A 2026 N/A	March 25, 2026	May 14, 2026	2026	View Filing
DEF 14A DEF 14A 2025 N/A	March 26, 2025	May 15, 2025	2025	View Filing
DEF 14A DEF 14A 2024 N/A	March 27, 2024	May 16, 2024	2024	View Filing
DEF 14A DEF 14A 2023 N/A	March 29, 2023	May 18, 2023	2023	View Filing
DEF 14A DEF 14A 2022 N/A	March 30, 2022	May 19, 2022	2022	View Filing
DEF 14A DEF 14A 2021 N/A	March 04, 2021	April 23, 2021	2021	View Filing
DEF 14A DEF 14A 2020 N/A	March 11, 2020	March 11, 2020	2020	View Filing
DEF 14A DEF 14A 2019 N/A	March 18, 2019	April 24, 2019	2019	View Filing
DEF 14A DEF 14A 2018 N/A	March 23, 2018	April 25, 2018	2018	View Filing
DEF 14A DEF 14A 2017 N/A	March 27, 2017	April 21, 2017	2017	View Filing

Showing 1 to 10 of 32 filings

Related Guides

Blog Categories

Continue your MCI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.